Accepted for/Published in: JMIR Rehabilitation and Assistive Technologies
Date Submitted: Sep 25, 2023
Open Peer Review Period: Sep 25, 2023 - Nov 20, 2023
Date Accepted: Nov 20, 2023
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Exoskeleton-assisted overground walking program in wheelchair users with spinal cord injury: Exploring potential effects on imaging and serum markers of bone strength
ABSTRACT
Background:
As many as 60% of individuals use a wheelchair long-term after a spinal cord injury (SCI). This mode of locomotion leads to chronic decline in lower-extremity weight-bearing activities and contributes to the development of severe sublesional osteoporosis and high rates of fragility fracture. Overground exoskeleton-assisted walking programs provide a novel opportunity to increase lower-extremity weight-bearing, with the potential to improve bone health.
Objective:
To measure the potential effects of an exoskeleton assisted walking program on lower-extremity bone strength and bone remodeling biomarkers in individuals with chronic (≥18 months) SCI who use a wheelchair.
Methods:
Ten participants completed a 16-week exoskeleton assisted walking program (34 individualized 1-hour sessions, progressing from 1 to 3 per week). Bone mineral density and bone strength markers (Dual-energy X-ray absorptiometry, DEXA: total body, and left arm, leg, total hip and femoral neck; peripheral quantitative computed tomography, pQCT: 25% of left femur and 66% of left tibia), as well as bone remodeling biomarkers (formation = osteocalcin, resorption = c-telopeptide) were measured pre- and post-intervention and compared using nonparametric tests. Changes were considered significant and meaningful if the following criteria were met: p<0.1, effect size ≥0.5 and relative variation >5%.
Results:
Significant and meaningful increases were observed at the femur (femoral neck bone mineral content, bone strength index, stress-strain index) and tibia (cortical cross-sectional area, polar moment of inertia) after the intervention. We also noted a decrease in estimated femoral cortical thickness. However, no changes in bone remodeling biomarkers were found.
Conclusions:
These initial results suggest promising improvements in bone strength markers after a 16-week exoskeleton-assisted walking program in individuals with chronic SCI. Additional research with larger sample sizes, longer interventions (possibly of greater loading intensity), and with combined modalities (e.g., pharmacotherapy or functional electrical stimulation) are warranted to strengthen current evidence. Clinical Trial: U.S. National Library of Medicine (registration number NCT03989752) on June 7, 2019.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.